GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Mkt Perform
SRPT
up 266.81 %

Sarepta Therapeutics Inc (SRPT) downgraded to Mkt Perform by JMP Securities

Posted on: Monday,  Jan 27, 2014  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Perform Sarepta Therapeutics Inc (NASDAQ: SRPT) on 01/27/2014. Previously JMP Securities rated Mkt Outperform Sarepta Therapeutics Inc (NASDAQ: SRPT)
on 04/11/2012., when the stock price was $6.60. Since then, Sarepta Therapeutics Inc has gained 266.82% as of 01/27/2014's recent price of $24.21.
If you would have followed the previous JMP Securities's recommendation on SRPT, you would have gained 266.81% of your investment in 656 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/27/2014 8:25 AM Hold
None
24.21
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD up  18.85 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/11/2012 10:25 AM Buy
None
6.60 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy